Concurrent Diffuse Alveolar Haemorrhage and Venous Thromboembolism in P-Anca Associated Vasculitis Treated With Rituximab

BMJ Case Reports - United Kingdom
doi 10.1136/bcr-2014-205197
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ

Related search

Advances in Management of Diffuse Alveolar Hemorrhage in ANCA-Associated Vasculitis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2016English

Treatment of Diffuse Alveolar Hemorrhage With Plasmapheresis Plus Steroids in Patients With MPO-ANCA Associated Vasculitis

Nihon Toseki Igakkai Zasshi
2008English

Should Rituximab Be Used to Prevent Relapse in Patients With ANCA-Associated Vasculitis?

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Venous Thrombotic Events in ANCA-associated Vasculitis: Incidence and Risk Factors

Kidney360
2020English

Anca-Associated Vasculitis

The Journal of scientific articles Health and Education millennium
2018English

AB0597 Low-Dose Rituximab as Induction Therapy for Japanese Patients With Anca-Associated Vasculitis

2017English

Rheumatoid Arthritis With ANCA Associated Vasculitis

Internet Journal of Rheumatology and Clinical Immunology
2018English

Combination Therapy With Rituximab and Cyclophosphamide for Remission Induction in ANCA Vasculitis

Kidney International Reports
Nephrology
2018English

Genetics of ANCA-Associated Vasculitis

Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy